{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:00Z","timestamp":1772165700320,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82400817"],"award-info":[{"award-number":["82400817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82200782"],"award-info":[{"award-number":["82200782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Young Scientist Project of Jiangxi Province","award":["20243BBI91026"],"award-info":[{"award-number":["20243BBI91026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04580-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:14:24Z","timestamp":1763464464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of CD19-guided B-cell depletion with rituximab plus steroids in refractory focal segmental glomerulosclerosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Liangliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"25","key":"4580_CR1","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"DD Vivette","year":"2011","unstructured":"Vivette DD, Kaskel, Ronald J, Falk. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398\u2013411.","journal-title":"N Engl J Med"},{"issue":"3","key":"4580_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.2017090958","volume":"29","author":"SD An","year":"2018","unstructured":"An SD, Vriese S, Sethi KA, Nath, et al. Differentiating Primary, Genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol. 2018;29(3):759\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"4580_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1681\/ASN.2021111472","volume":"33","author":"LM Yu Ellen","year":"2022","unstructured":"Chan Eugene Yu-Hin, Yu Ellen LM. Long-Term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study. J Am Soc Nephrol. 2022;33:1193\u2013207.","journal-title":"J Am Soc Nephrol"},{"key":"4580_CR4","doi-asserted-by":"publisher","first-page":"e15927","DOI":"10.1097\/MD.0000000000015927","volume":"98","author":"L Tan Liping","year":"2019","unstructured":"Tan Liping L, Shaojun Y, Haiping, et al. Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials. Med (Baltim). 2019;98:e15927.","journal-title":"Med (Baltim)"},{"key":"4580_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jpeds.2018.01.008","volume":"197","author":"C Jellouli Manel","year":"2018","unstructured":"Jellouli Manel C, Rim M, Bayen, et al. Rituximab in the management of pediatric Steroid-Resistant nephrotic syndrome: A systematic review. J Pediatr. 2018;197:191\u2013e1971.","journal-title":"J Pediatr"},{"issue":"9","key":"4580_CR6","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2014080799","volume":"26","author":"R Pietro Ravani","year":"2015","unstructured":"Pietro Ravani R, Rossi A, Bonanni, et al. Rituximab in children with Steroid-Dependent nephrotic syndrome: A Multicenter, Open-Label, Noninferiority, randomized controlled trial. J Am Soc Nephrol. 2015;26(9):2259\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4580_CR7","first-page":"1042","volume":"14","author":"Y Xue Cheng","year":"2020","unstructured":"Xue Cheng Y, Bo X, Jing, et al. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis. Clin Kidney J. 2020;14(4):1042\u201354.","journal-title":"Clin Kidney J"},{"key":"4580_CR8","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.ekir.2022.05.024","volume":"7","author":"F Martina Tedesco","year":"2022","unstructured":"Martina Tedesco F, Mescia I, Pisani, et al. The role of rituximab in primary focal segmental glomerular sclerosis of the adult. Kidney Int Rep. 2022;7:1878\u201386.","journal-title":"Kidney Int Rep"},{"key":"4580_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000535010","volume":"55","author":"Y Lan Lan","year":"2023","unstructured":"Lan Lan Y, Lin B, Yu, et al. Efficacy of rituximab for minimal change disease and focal segmental glomerulosclerosis with frequently relapsing or Steroid-Dependent nephrotic syndrome in adults: A Chinese multicenter retrospective Study.[J]. Am J Nephrol. 2023;55:25\u201336.","journal-title":"Am J Nephrol"},{"key":"4580_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"DD Vivette","year":"2004","unstructured":"Vivette DD, Fogo, Jan A, Bruijn, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368\u201382.","journal-title":"Am J Kidney Dis"},{"key":"4580_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"H Brad","year":"2021","unstructured":"Brad H, Rovin SG, Adler J, Barratt, et al. Kidney disease: improving global outcomes (KDIGO) glomerular diseases work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1\u2013276.","journal-title":"Kidney Int"},{"key":"4580_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.mayocp.2017.09.011","volume":"92","author":"S Hommos Musab","year":"2017","unstructured":"Hommos Musab S, De Vriese An S, Alexander Mariam P, et al. The incidence of primary vs secondary focal segmental glomerulosclerosis: A clinicopathologic study. Mayo Clin Proc. 2017;92:1772\u201381.","journal-title":"Mayo Clin Proc"},{"key":"4580_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0272-6386(99)70257-X","volume":"33","author":"M Praga","year":"1999","unstructured":"Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis. 1999;33:52\u20138.","journal-title":"Am J Kidney Dis"},{"key":"4580_CR14","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1159\/000508099","volume":"144","author":"A Shabaka","year":"2020","unstructured":"Shabaka A. Ana Tato Ribera, Gema Fern\u00e1ndez-Ju\u00e1rez. Focal segmental glomerulosclerosis: State-of-the-Art and clinical perspective. Nephron. 2020;144:0.","journal-title":"Nephron"},{"issue":"8","key":"4580_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, Hindi SE, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.[J]. Nat Med. 2011;17(8):952\u201360.","journal-title":"Nat Med"},{"issue":"10","key":"4580_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"G Jochen Reiser","year":"2004","unstructured":"Jochen Reiser G, von Gersdorff M, Loos, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113(10):1390\u20137.","journal-title":"J Clin Invest"},{"key":"4580_CR17","first-page":"0","volume":"23","author":"W Changli","year":"2012","unstructured":"Changli W, Howard T, Jing, Li, et al. Circulating SuPAR in two cohorts of primary FSGS. J Am Soc Nephrol. 2012;23:0.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"4580_CR18","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"T Ellen","year":"2010","unstructured":"Ellen T, McCarthy M, Sharma, Virginia J, Savin. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010;5(11):2115\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4580_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clim.2008.01.011","volume":"127","author":"C Liossis Stamatis-Nick","year":"2008","unstructured":"Liossis Stamatis-Nick C, Sfikakis Petros P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol. 2008;127:280\u20135.","journal-title":"Clin Immunol"},{"issue":"1","key":"4580_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12882-018-1177-x","volume":"19","author":"JL Nada Alachkar","year":"2018","unstructured":"Nada Alachkar JL, Matar D, et al. Monitoring SuPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab. BMC Nephrol. 2018;19(1):361.","journal-title":"BMC Nephrol"},{"key":"4580_CR21","first-page":"0","volume":"3","author":"J Alessia Fornoni","year":"2011","unstructured":"Alessia Fornoni J, Sageshima C, Wei, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011;3:0.","journal-title":"Sci Transl Med"},{"key":"4580_CR22","doi-asserted-by":"crossref","unstructured":"Magnasco A, Ravani P, Edefonti A, et al. Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol, 2012;23(6):1117-24.","DOI":"10.1681\/ASN.2011080775"},{"issue":"8","key":"4580_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2215\/CJN.00570109","volume":"4","author":"F-F Gema","year":"2009","unstructured":"Gema F-F, Segarra A, Gonz\u00e1lez E, et al. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2009;4(8):1317\u201323.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"4580_CR24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2215\/CJN.11941115","volume":"11","author":"C-Y Chan","year":"2016","unstructured":"Chan C-Y, Liu ID, Resontoc LP, et al. T lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS. Clin J Am Soc Nephrol. 2016;11(8):1360\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4580_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ndt\/gfab323","volume":"37","author":"G Marco Allinovi","year":"2021","unstructured":"Marco Allinovi G, Trivioli G, Lugli, et al. Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transpl. 2021;37:789\u201391.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"4580_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1681\/ASN.0000000520","volume":"36","author":"A Philipp Gauckler","year":"2025","unstructured":"Philipp Gauckler A, Matyjek S, Kapsia, et al. Long-Term outcomes of Rituximab-Treated adult patients with podocytopathies. J Am Soc Nephrol. 2025;36(4):668\u201378.","journal-title":"J Am Soc Nephrol"},{"key":"4580_CR27","unstructured":"Piero R, Barbara R, Paolo C, et al. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol, 2014 Apr;25(4):850-63"},{"key":"4580_CR28","doi-asserted-by":"crossref","unstructured":"Laurence HB Jr, Fernando CF, David MB, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol, 2011 Aug;22(8):1543-50","DOI":"10.1681\/ASN.2010111125"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04580-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04580-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:14:28Z","timestamp":1763464468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04580-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4580"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04580-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7617059\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as per the Declaration of Helsinki and approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (No.[2025B]0222) and granted a waiver of informed consent. The requirement for consent was waived because the research involved only anonymised data extracted from medical records, and re-identification of participants was not possible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"645"}}